⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL170308 | 1.00 | — | — | |
| SCHEMBL162294 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL283015 | 0.98 | CYP2D6 (0.41) | — | |
| SCHEMBL28861034 | 0.98 | CYP2D6 (0.41) | — | |
| SCHEMBL28853863 | 0.98 | CYP2D6 (0.41) | — | |
| Hydrochloric Acid SCHEMBL191366 | 0.98 | CYP2D6 (0.41) | — | |
| Hydrochloric Acid SCHEMBL780213 | 0.98 | CYP2D6 (0.41) | — | |
| SCHEMBL4492257 | 0.98 | CYP2D6 (0.41) | — | |
| Hydrochloric Acid SCHEMBL28324857 | 0.98 | CYP2D6 (0.41) | — | |
| Hydrochloric Acid SCHEMBL26648780 | 0.98 | CYP2D6 (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122057359-A | Positively charged composite nanofiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| CN-118807485-B | Gas separation membrane, preparation method and application thereof in carbon dioxide capture | 北京九章环境工程股份有限公司 | 2024-11-15 | — | — | CN | claimed |
| CN-118807485-A | Gas separation membrane, preparation method and application thereof in carbon dioxide capture | 北京九章环境工程股份有限公司 | 2024-10-22 | — | — | CN | claimed |
| CN-115724801-A | Metal complex glass material with circular polarization luminescence characteristic and preparation method thereof | 北京师范大学 | 2023-03-03 | — | — | CN | claimed |
| CN-110267953-A | Tetrahydroimidazo [4,5-C ] pyridine derivatives as inducers of PD-L1 internalization | 因赛特公司 | 2019-09-20 | — | — | CN | claimed |
| US-20140273458-A1 | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-18 | — | — | US | claimed |
| EP-2779217-A2 | Chemical mechanical planarization for tungsten-containing substrates | AIR PRODUCTS AND CHEMICALS, INC. (US) | 2014-09-17 | — | — | EP | claimed |
| CN-104046246-A | Chemical Mechanical Planarization for Tungsten-Containing Substrates | AIR PROD & CHEM | 2014-09-17 | — | — | CN | claimed |
| US-12637702-B2 | Process for preparing substituted imidazo[1,5-α]pyrazines | HOFFMANN-LA ROCHE INC. (US) | 2026-05-26 | — | — | US | disclosed |
| CN-122057359-A | Positively charged composite nanofiltration membrane and preparation method and application thereof | 中国石油化工股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| US-12544448-B2 | C40-, C28-, and C-32-linked rapamycin analogs as mTOR inhibitors | Revolution Medicines, Inc. (US) | 2026-02-10 | — | — | US | disclosed |
| US-12351575-B2 | 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection | HOFFMANN-LA ROCHE INC. (US) | 2025-07-08 | — | — | US | disclosed |
| CN-119752387-A | Aldehyde-free polyurethane adhesive for high-conductivity leather products containing imidazole heterocycle ionic liquid and preparation method thereof | 广东菲安妮皮具股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20250108117-A1 | C40-, C28-, and C-32-Linked Rapamycin Analogs as mTOR Inhibitors | WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT | 2025-04-03 | — | — | US | disclosed |
| US-6153757-A | A PRODRUG, SALT OR SOLVATE AS ANTITUMOR AGENT AND ENZYME INHIBITOR FOR INHIBITING METALLOPROTEINASES, TUMOR NECROSIS FACTOR | AGOURON PHARMACEUTICALS, INC. (US) | 2000-11-28 | — | — | US | disclosed |
| WO-2000035922-A1 | 2,3,4,4A-TETRAHYDRO-1H-PYRAZINO(1,2-A)QUINOXALIN-5(6H)ONE DERIVATES BEING 5HT2C AGONISTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |
| CN-1207734-A | Metalloprotease inhibitors, pharmaceutical compositions containing them and their use as medicaments, process and intermediates for their preparation | AGOURON PHARMA (US) | 1999-02-10 | — | — | CN | disclosed |
| EP-0874830-A1 | METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES, AND METHODS AND INTERMEDIATES USEFUL FOR THEIR PREPARATION | AGOURON PHARMACEUTICALS, INC. (US) | 1998-11-04 | — | — | EP | disclosed |
| US-5753653-A | Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses | AGOURON PHARMACEUTICALS, INC. (US) | 1998-05-19 | — | — | US | disclosed |
| WO-1997020824-A1 | METALLOPROTEINASE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR PHARMACEUTICAL USES, AND METHODS AND INTERMEDIATES USEFUL FOR THEIR PREPARATION | AGOURON PHARMACEUTICALS, INC. (US) | 1997-06-12 | — | — | WO | disclosed |